Monocyte Chemoattractant Protein-1 is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice

Weihua Ni, Shiro Kitamoto, Minako Ishibashi, Makoto Usui, Shujiro Inoue, Ken Ichi Hiasa, Qingwei Zhao, Ken Ichi Nishida, Akira Takeshita, Kensuke Egashira

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objective-Chronic inflammatory processes might be involved in the progression and destabilization of atherosclerotic plaques. Therefore, identification of the mechanism underlying arterial inflammatory function might lead to the development of novel therapeutic strategies. Angiotensin II (AngII) is implicated in atherogenesis by activating the vascular inflammation system, mainly through monocyte chemotaxis. Therefore, we hypothesized that AngII increases plaque size and promotes destabilization of established atheromas by activating the monocyte chemoattractant protein-1 (MCP-1) pathway. Methods and Results-We report here that 4-week infusion of AngII not only increased plaque size but also induced a destabilization phenotype (ie, increased macrophages and lipids and decreased collagen and smooth muscle cells) of pre-existing atherosclerotic lesions of hypercholesterolemic mice. AngII also enhanced the gene expression of inflammatory cytokines (TNFα, IL-6, etc.) and chemokines (MCP-1, CCR2, etc). Blockade of MCP-1, by transfecting the deletion mutant of the human MCP-1 gene into the skeletal muscles, limited AngII-induced progression and destabilization of established atherosclerotic lesions and suppressed the induction of proinflammatory genes. Conclusions-These data suggest that MCP-1 functions as a central inflammatory mediator in the AngII-induced progression and changes in plaque composition of established atheroma.

Original languageEnglish
Pages (from-to)534-539
Number of pages6
JournalArteriosclerosis, thrombosis, and vascular biology
Volume24
Issue number3
DOIs
Publication statusPublished - Mar 1 2004

Fingerprint

Chemokine CCL2
Angiotensin II
Atherosclerosis
Atherosclerotic Plaques
Chemotaxis
Chemokines
Genes
Smooth Muscle Myocytes
Blood Vessels
Monocytes
Interleukin-6
Skeletal Muscle
Collagen
Macrophages
Cytokines
Inflammation
Phenotype
Lipids
Gene Expression

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Monocyte Chemoattractant Protein-1 is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice. / Ni, Weihua; Kitamoto, Shiro; Ishibashi, Minako; Usui, Makoto; Inoue, Shujiro; Hiasa, Ken Ichi; Zhao, Qingwei; Nishida, Ken Ichi; Takeshita, Akira; Egashira, Kensuke.

In: Arteriosclerosis, thrombosis, and vascular biology, Vol. 24, No. 3, 01.03.2004, p. 534-539.

Research output: Contribution to journalArticle

Ni, Weihua ; Kitamoto, Shiro ; Ishibashi, Minako ; Usui, Makoto ; Inoue, Shujiro ; Hiasa, Ken Ichi ; Zhao, Qingwei ; Nishida, Ken Ichi ; Takeshita, Akira ; Egashira, Kensuke. / Monocyte Chemoattractant Protein-1 is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice. In: Arteriosclerosis, thrombosis, and vascular biology. 2004 ; Vol. 24, No. 3. pp. 534-539.
@article{b4b498b1b65a48ccbb4e3a9f5bbce03f,
title = "Monocyte Chemoattractant Protein-1 is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice",
abstract = "Objective-Chronic inflammatory processes might be involved in the progression and destabilization of atherosclerotic plaques. Therefore, identification of the mechanism underlying arterial inflammatory function might lead to the development of novel therapeutic strategies. Angiotensin II (AngII) is implicated in atherogenesis by activating the vascular inflammation system, mainly through monocyte chemotaxis. Therefore, we hypothesized that AngII increases plaque size and promotes destabilization of established atheromas by activating the monocyte chemoattractant protein-1 (MCP-1) pathway. Methods and Results-We report here that 4-week infusion of AngII not only increased plaque size but also induced a destabilization phenotype (ie, increased macrophages and lipids and decreased collagen and smooth muscle cells) of pre-existing atherosclerotic lesions of hypercholesterolemic mice. AngII also enhanced the gene expression of inflammatory cytokines (TNFα, IL-6, etc.) and chemokines (MCP-1, CCR2, etc). Blockade of MCP-1, by transfecting the deletion mutant of the human MCP-1 gene into the skeletal muscles, limited AngII-induced progression and destabilization of established atherosclerotic lesions and suppressed the induction of proinflammatory genes. Conclusions-These data suggest that MCP-1 functions as a central inflammatory mediator in the AngII-induced progression and changes in plaque composition of established atheroma.",
author = "Weihua Ni and Shiro Kitamoto and Minako Ishibashi and Makoto Usui and Shujiro Inoue and Hiasa, {Ken Ichi} and Qingwei Zhao and Nishida, {Ken Ichi} and Akira Takeshita and Kensuke Egashira",
year = "2004",
month = "3",
day = "1",
doi = "10.1161/01.ATV.0000118275.60121.2b",
language = "English",
volume = "24",
pages = "534--539",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Monocyte Chemoattractant Protein-1 is an Essential Inflammatory Mediator in Angiotensin II-Induced Progression of Established Atherosclerosis in Hypercholesterolemic Mice

AU - Ni, Weihua

AU - Kitamoto, Shiro

AU - Ishibashi, Minako

AU - Usui, Makoto

AU - Inoue, Shujiro

AU - Hiasa, Ken Ichi

AU - Zhao, Qingwei

AU - Nishida, Ken Ichi

AU - Takeshita, Akira

AU - Egashira, Kensuke

PY - 2004/3/1

Y1 - 2004/3/1

N2 - Objective-Chronic inflammatory processes might be involved in the progression and destabilization of atherosclerotic plaques. Therefore, identification of the mechanism underlying arterial inflammatory function might lead to the development of novel therapeutic strategies. Angiotensin II (AngII) is implicated in atherogenesis by activating the vascular inflammation system, mainly through monocyte chemotaxis. Therefore, we hypothesized that AngII increases plaque size and promotes destabilization of established atheromas by activating the monocyte chemoattractant protein-1 (MCP-1) pathway. Methods and Results-We report here that 4-week infusion of AngII not only increased plaque size but also induced a destabilization phenotype (ie, increased macrophages and lipids and decreased collagen and smooth muscle cells) of pre-existing atherosclerotic lesions of hypercholesterolemic mice. AngII also enhanced the gene expression of inflammatory cytokines (TNFα, IL-6, etc.) and chemokines (MCP-1, CCR2, etc). Blockade of MCP-1, by transfecting the deletion mutant of the human MCP-1 gene into the skeletal muscles, limited AngII-induced progression and destabilization of established atherosclerotic lesions and suppressed the induction of proinflammatory genes. Conclusions-These data suggest that MCP-1 functions as a central inflammatory mediator in the AngII-induced progression and changes in plaque composition of established atheroma.

AB - Objective-Chronic inflammatory processes might be involved in the progression and destabilization of atherosclerotic plaques. Therefore, identification of the mechanism underlying arterial inflammatory function might lead to the development of novel therapeutic strategies. Angiotensin II (AngII) is implicated in atherogenesis by activating the vascular inflammation system, mainly through monocyte chemotaxis. Therefore, we hypothesized that AngII increases plaque size and promotes destabilization of established atheromas by activating the monocyte chemoattractant protein-1 (MCP-1) pathway. Methods and Results-We report here that 4-week infusion of AngII not only increased plaque size but also induced a destabilization phenotype (ie, increased macrophages and lipids and decreased collagen and smooth muscle cells) of pre-existing atherosclerotic lesions of hypercholesterolemic mice. AngII also enhanced the gene expression of inflammatory cytokines (TNFα, IL-6, etc.) and chemokines (MCP-1, CCR2, etc). Blockade of MCP-1, by transfecting the deletion mutant of the human MCP-1 gene into the skeletal muscles, limited AngII-induced progression and destabilization of established atherosclerotic lesions and suppressed the induction of proinflammatory genes. Conclusions-These data suggest that MCP-1 functions as a central inflammatory mediator in the AngII-induced progression and changes in plaque composition of established atheroma.

UR - http://www.scopus.com/inward/record.url?scp=12144288691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144288691&partnerID=8YFLogxK

U2 - 10.1161/01.ATV.0000118275.60121.2b

DO - 10.1161/01.ATV.0000118275.60121.2b

M3 - Article

C2 - 14739122

AN - SCOPUS:12144288691

VL - 24

SP - 534

EP - 539

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 3

ER -